You can ask questions in real time, and the provider can observe you and respond to your concerns immediately
Oral Incretins: The convenience of oral administration is a major draw, and several companies, including Lilly (orforglipron) and Structure Therapeutics (GSBR-1290) , are developing oral small molecule GLP-1 receptor agonists that could offer a more accessible option
Brand-name restrictions also limit access, as some plans only cover one GLP-1 option while excluding alternatives like tirzepatide
( 10.1016/S0140-6736(0861206-4) [DOI] [PubMed] [Google Scholar] 8.Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD
It works through a hormone-based mechanism that targets appetite regulation rather than relying only on external diet or exercise interventions
They are strengthening long-term commercial demand